These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20005103)

  • 61. Extended-release gabapentin in post-herpetic neuralgia.
    Thomas B; Farquhar-Smith P
    Expert Opin Pharmacother; 2011 Nov; 12(16):2565-71. PubMed ID: 21942929
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro/in vivo characterization of melt-molded gabapentin-loaded poly(epsilon-caprolactone) implants for sustained release in animal studies.
    Carcaboso AM; Chiappetta DA; Höcht C; Blake MG; Boccia MM; Baratti CM; Sosnik A
    Eur J Pharm Biopharm; 2008 Oct; 70(2):666-73. PubMed ID: 18590815
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gabapentin in dermatology.
    Misery L
    Dermatology; 2005; 211(2):79-80. PubMed ID: 16088149
    [No Abstract]   [Full Text] [Related]  

  • 64. Biphasic effects of chronic intrathecal gabapentin administration on the expression of protein kinase C gamma in the spinal cord of neuropathic pain rats.
    Yeh CY; Chung SC; Tseng FL; Tsai YC; Liu YC
    Acta Anaesthesiol Taiwan; 2011 Dec; 49(4):144-8. PubMed ID: 22221687
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A population pharmacokinetic model of gabapentin developed in nonparametric adaptive grid and nonlinear mixed effects modeling.
    Carlsson KC; van de Schootbrugge M; Eriksen HO; Moberg ER; Karlsson MO; Hoem NO
    Ther Drug Monit; 2009 Feb; 31(1):86-94. PubMed ID: 19077930
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gabapentin hybrid peptides and bioconjugates.
    Lebedyeva IO; Ostrov DA; Neubert J; Steel PJ; Patel K; Sileno SM; Goncalves K; Ibrahim MA; Alamry KA; Katritzky AR
    Bioorg Med Chem; 2014 Feb; 22(4):1479-86. PubMed ID: 24468631
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Polymorphism control of an active pharmaceutical ingredient beneath calixarene-based Langmuir monolayers.
    Tulli LG; Moridi N; Wang W; Helttunen K; Neuburger M; Vaknin D; Meier W; Shahgaldian P
    Chem Commun (Camb); 2014 Apr; 50(30):3938-40. PubMed ID: 24599407
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Umpolung reactivity of difluoroenol silyl ethers with amines and amino alcohols. application to the synthesis of enantiopure alpha-difluoromethyl amines and amino acids.
    Huguenot F; Billac A; Brigaud T; Portella C
    J Org Chem; 2008 Apr; 73(7):2564-9. PubMed ID: 18331052
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stability of gabapentin in SyrSpend SF.
    Sorenson B; Voudrie MA; Gehrig D
    Int J Pharm Compd; 2012; 16(4):347-9. PubMed ID: 23050395
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel mast cell-stabilising amine derivatives of 3,4 dihydronaphthalen-1(2H)-one and 6,7,8,9-tetrahydro-5H-benzo[7]annulen-5-one.
    Barlow JW; Zhang T; Woods O; Byrne AJ; Walsh JJ
    Med Chem; 2011 May; 7(3):213-23. PubMed ID: 21486212
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Gabapentin in comorbid anxiety and substance use.
    Verduin ML; McKay S; Brady KT
    Am J Addict; 2007; 16(2):142-3. PubMed ID: 17453618
    [No Abstract]   [Full Text] [Related]  

  • 72. Treatment of neuropathic pain in acute intermittent porphyria with gabapentin.
    Lin TC; Lai SL; Hsu SP; Ro LS
    J Formos Med Assoc; 2013 Sep; 112(9):578-9. PubMed ID: 23735466
    [No Abstract]   [Full Text] [Related]  

  • 73. Asymmetric synthesis of enantioenriched (+)-elaeokanine A.
    Dieter RK; Chen N
    J Org Chem; 2006 Jul; 71(15):5674-8. PubMed ID: 16839148
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Skin permeation and antinociception of topical gabapentin formulations.
    Bryson E; Asbill S; Sweitzer S
    Int J Pharm Compd; 2014; 18(6):504-11. PubMed ID: 25906628
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pregabalin and duloxetine for the treatment of neuropathic pain disorders.
    Terneus W
    J Pain Palliat Care Pharmacother; 2007; 21(1):79-84. PubMed ID: 17430838
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A bicyclic cispentacin derivative as a novel reverse turn inducer in a GnRH mimetic.
    Langer O; Kählig H; Zierler-Gould K; Bats JW; Mulzer J
    J Org Chem; 2002 Oct; 67(20):6878-83. PubMed ID: 12353977
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Generation of Molecular Complexity from Cyclooctatetraene: Preparation of Aminobicyclo[5.1.0]octitols.
    El-Mansy MF; Flister M; Lindeman S; Kalous K; Sem DS; Donaldson WA
    Chemistry; 2015 Jul; 21(30):10886-95. PubMed ID: 26096989
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MechanoAPI-ILs: Pharmaceutical Ionic Liquids Obtained through Mechanochemical Synthesis.
    Martins IC; Oliveira MC; Diogo HP; Branco LC; Duarte MT
    ChemSusChem; 2017 Apr; 10(7):1360-1363. PubMed ID: 28199779
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Highly stereoselective one-pot synthesis of bicyclic isoxazolidines with five stereogenic centers by an organocatalytic process.
    Zhu D; Lu M; Dai L; Zhong G
    Angew Chem Int Ed Engl; 2009; 48(33):6089-92. PubMed ID: 19598191
    [No Abstract]   [Full Text] [Related]  

  • 80. Characteristic structural parameters for the γ-peptide 14-helix: importance of subunit preorganization.
    Guo L; Zhang W; Reidenbach AG; Giuliano MW; Guzei IA; Spencer LC; Gellman SH
    Angew Chem Int Ed Engl; 2011 Jun; 50(26):5843-6. PubMed ID: 21567680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.